Biopharmaceutical firm AstraZeneca will be creating 100 new jobs at its new facility which is planned to be located in Dublin.
The next-generation active pharmaceutical ingredient manufacturing facility will be located at the Alexion Campus in College Park in Blanchardstown.
The 100 new jobs that will be created include scientists and engineers while further indirect jobs will also be created by the firm.
The project has been developed with the support and collaboration of Industrial Development Agency (IDA) Ireland.
Expressing delight towards the company’s Dublin investment, AstraZeneca CEO Pascal Soriot stated, “With the support of the IDA, it will create highly skilled jobs, nurture the country’s dynamic life sciences sector and allow for the development of high value-added medicines,”.
Taoiseach Micheál Martin also welcomed the development while stating that AstraZeneca “joins the very strong and successful network of global life sciences companies we have in Ireland” as a result of their decision.
IMAGE – “AstraZeneca introduces new safe vaccine” (CC BY 2.0) by wuestenigel